What's behind the frenetics on genetics
Related Articles
- ...while Germans flee paperwork. Toro, Taryn // New Scientist;8/8/92, Vol. 135 Issue 1833, p6
Reports that Germany's law regulating biotechnology is driving the industry out of the country and stifling good research in genetic engineering. Its effect on students entering the field; The law itself is not the problem but the amount of paperwork; Four categories of experiments the law covers.
- Stolen fruit. // New Scientist;7/24/93, Vol. 139 Issue 1883, p11
Reports on the Federal Bureau of Investigation's (FBI) investigation of international biotechnology espionage. Stealing of American biotechnology knowhow by foreign companies; Visit of FBI agents to companies in the San Francisco Bay area to warn them.
- US tackles the legal labyrinth of biotechnology. Coghlan, Andy // New Scientist;7/11/92, Vol. 135 Issue 1829, p7
Reveals that the administration will publish a major policy document that will resolve many uncertainties over the legal maze biotechnological companies must go through. The assumption the document is based on; The document will `show once and for all who regulates what'; Some of the...
- Prospects for new biotech regulations. // U.S. News & World Report;3/4/91, Vol. 110 Issue 8, p14
Details some of the regulations suggested by the White House Council on Competitiveness (headed by Vice President Dan Quayle) that would simplify the muddled approval process for genetically engineered crops, animals and pesticides. New regulations would treat genetically altered plants the...
- Overregulation could damage US biotechnology, says report. Lehrman, Sally // Nature;10/15/1992, Vol. 359 Issue 6396, p569
Outlines the results of a report by the National Biotechnology Policy Board which says that existing United States (US) regulations for field tests of genetically engineered organisms are stifling research. Emphasis on social costs of regulatory delays; Recommendation of a pilot study to...
- OTA panel opens inquiry into patenting of genes. Macilwain, Colin // Nature;4/1/1993, Vol. 362 Issue 6419, p386
Reports that members of a panel meeting last week for the first time to advise the US Congress on gene patenting and the human genome project believe that action is needed to protect biotechnological innovation but do not agree on what should be done. Office of Technology Assessment (OTA);...
- US biotechnology policy. // Nature;3/5/1992, Vol. 356 Issue 6364, p1
Opinion. Applauds the policy issued by the Bush administration on regulating biotechnology. The policy, which finds no distinction between cellular and classical methods or modifying organisms; Recombinant DNA technology; Keeping regulatory barriers low; More.
- Protecting US biotech firms. Gershon, D. // Nature;7/4/1991, Vol. 352 Issue 6330, p4
States that two bills have been introduced into Congress that are intended to reform United States patent and trade law and protect the United States biotechnology industry against unfair foreign competition. The legislation would overturn a 1985 court ruling and provide the patent office with...
- ...while German report confronts industry claims. MacKenzie, Deborah // New Scientist;10/16/93, Vol. 140 Issue 1895, p5
Cites findings of the German parliamentary committee on biotechnology regarding the effect of regulations on biotechnology companies. Claim by Chemical Industries Federation; Approval of regulation reform; Comparison with biotechnology regulations in the United States and Japan; Effect on...
